Analyst Team Sees Strong Biotech Buyout Market in 2014
Analysts at at Merrill Lynch see 2014 as a promising year for biotech mergers and acquisitions. A new research report shows which companies they believe will make acquisitions or which will be…
Analysts at at Merrill Lynch see 2014 as a promising year for biotech mergers and acquisitions. A new research report shows which companies they believe will make acquisitions or which will be…
The new year is well under way and the major firms on Wall Street are all presenting their best stock ideas for 2014. The team at Cantor Fitzgerald is no exception.
Jon OggStocks have pulled back marginally but are still close to all-time highs. We are sliding into year-end, and investors are trying to position themselves for 2014 and beyond. 24/7 Wall St. reviews…
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you…
Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for…
The three major U.S. stock indexes opened lower this morning on the absence of any big macroeconomic data in Asia or Europe. Tensions between China and Japan over a handful of islands…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Wednesday. Applied Materials Inc. (NASDAQ: AMAT) Raised to Neutral at Goldman Sachs. Ariba…
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added and deleted from them as money management firms often buy and sell shares,…
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was indicated to open a bit weak on Tuesday ahead of the open on news that the company has announced an underwritten public offering of 7,883,366 of its ordinary…
The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always the case that some of the top performing stocks each year come…
2010 has been an interesting year in biotech and in biohealth stocks, even if it has lacked some of the ten-baggers that were seen in 2009. In 2009, companies like Jazz Pharmaceuticals,…
Active traders and day traders have many stocks to choose from this Friday morning. We are tracking news and moves in shares of National Bank of Greece S.A. (NYSE: NBG), Starbucks Corporation…
The world of biotech and biohealth is seeing a flurry of news today. This is bringing on many winners and losers in the sector. We are tracking the news and the moves…
Earnings season is just getting underway and the Dow Jones Industrial Average hit 11,000 on Friday. There are many stocks to watch outside of earnings this week. The cast of characters in…
There are many stocks for active traders and day traders to pick from this Monday morning, and most are not on earnings. We are tracking key trading action in 3PAR, Inc. (NYSE:…